Evidence map›Paper›PMID 36097778›Full record

ArticleZhong nan da xue xue bao. Yi xue ban = Journal of Central South University. Medical sciences2022

Anti

Heng Yang, Chen Zhang

Open access · greenAbstract read
In one paragraph

Article in Zhong nan da xue xue bao. Yi xue ban = Journal of Central South University. Medical sciences, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.1field-weighted citation impact, top 60% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 1 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 1 institution in 1 country.

Heng YangDepartment of Neurology, Third Xiangya Hospital, Central South University, Changsha 410013, China. 873008352@qq.com.
Chen ZhangDepartment of Neurology, Third Xiangya Hospital, Central South University, Changsha 410013, China. 21689952@qq.com.
Central South University · CN

Funding

the National Natural Science Foundation of China 81801295
6 · The paper itself

Abstract

objectivesEpilepsy is a syndrome of central nervous system dysfunction caused by many reasons, which is mainly characterized by abnormal discharge of neurons in the brain. Therefore, finding new targets for epilepsy therapy has always been the focus and hotspot in neurological research field. Studies have found that 2-deoxy-

methodsA magnesium-free epilepsy model was established and randomly divided into a control group, an epilepsy group (EP group), an EP+2-DG group, and miR-194 groups (including EP+miR-194 mimic, EP+miR-194 mimic+2-DG, EP+miR-194 mimic control, EP+miR-194 inhibitor, EP+miR-194 inhibitor+2-DG, and EP+miR-194 inhibitor control groups). The 2-DG was used to intervene miR-194 mimics, patch-clamp method was used to detect the spontaneous recurrent epileptiform discharges, real-time PCR was used to detect neuronal

resultsCompared with the control group, there was no significant difference in the amplitude of spontaneous discharge potential in the EP group (

conclusionsThe 2-DG might play an anti-epilepsy effect by up-regulating K

Indexed as

EpilepsyMicroRNAsPotassium Channels, Inwardly RectifyingAdenosine TriphosphateAnticonvulsantsDeoxyglucoseGlucoseHumansRNA, MessengerSignal TransductionAdenosine TriphosphateAnticonvulsantsDeoxyglucoseGlucoseMicroRNAsMIRN194 microRNA, humanPotassium Channels, Inwardly RectifyingRNA, Messenger2-deoxy- D-glucoseepilepsyKir6.1Kir6.2miR-194

Identifiers

PMID36097778
PMCPMC10950105
OpenAlexW4295454169

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.